DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $18,497,000 | +37.8% | 495,638 | -5.6% | 0.67% | +39.3% |
| Q1 2021 | $13,423,000 | +4.3% | 524,932 | -10.2% | 0.48% | +13.3% |
| Q4 2020 | $12,873,000 | +38.3% | 584,342 | +12.9% | 0.43% | +11.5% |
| Q3 2020 | $9,310,000 | -29.6% | 517,484 | -0.6% | 0.38% | -33.5% |
| Q2 2020 | $13,228,000 | +7.8% | 520,787 | -22.1% | 0.58% | -18.9% |
| Q1 2020 | $12,273,000 | -20.6% | 668,124 | -4.7% | 0.71% | +8.7% |
| Q4 2019 | $15,451,000 | +23.2% | 701,341 | -19.7% | 0.65% | +11.4% |
| Q3 2019 | $12,545,000 | -19.3% | 873,609 | -11.5% | 0.59% | -6.1% |
| Q2 2019 | $15,540,000 | +6.5% | 986,657 | -1.0% | 0.62% | +5.1% |
| Q1 2019 | $14,597,000 | +35.2% | 996,360 | -1.4% | 0.59% | +11.9% |
| Q4 2018 | $10,800,000 | -27.2% | 1,010,330 | +3.9% | 0.53% | -2.6% |
| Q3 2018 | $14,842,000 | +100.8% | 972,622 | +61.2% | 0.54% | +95.3% |
| Q2 2018 | $7,393,000 | +2598.2% | 603,508 | +2002.5% | 0.28% | +2436.4% |
| Q1 2018 | $274,000 | +3.0% | 28,704 | -2.7% | 0.01% | +10.0% |
| Q4 2017 | $266,000 | -82.9% | 29,504 | -57.8% | 0.01% | -87.2% |
| Q1 2015 | $1,554,000 | – | 69,945 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|